The company is the largest Tibetan medicine manufacturer in China, mainly engaged in the research and development, production and sales of new Tibetan medicines, covering cardiovascular and cerebrovascular diseases, respiratory system, digestive system, urogenital system, nervous system, musculoskeletal system, gynecological diseases and other fields. Among them, a series of topical analgesic drugs, represented by Zheng Qi Xiaotong Plaster, have been selling well for many years, with high clinical effective rate and nearly 200 million people in mainland China. For six consecutive years, it ranked first in the national external analgesic market, ranked first in the surgical category of traditional Chinese medicine in the first OTC product list, and ranked among the key brands of over-the-counter drugs, and was listed as "national protected varieties of traditional Chinese medicine" and "national confidential varieties". The enterprise won the first batch of national innovative enterprises, key high-tech enterprises of the National Torch Program, national enterprise technology center and the implementation unit of the national "Eleventh Five-Year Plan" key scientific and technological support projects. The enterprise owns 22 patented technologies, including 9 invention patents and 6 drug approval numbers, including 9 exclusive varieties and 5 protected varieties of traditional Chinese medicine.